Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$222.59 - $267.94 $22,481 - $27,061
-101 Reduced 10.63%
849 $219,000
Q3 2023

Oct 13, 2023

SELL
$253.3 - $285.89 $1,266 - $1,429
-5 Reduced 0.52%
950 $244,000
Q2 2023

Jul 25, 2023

BUY
$275.25 - $318.06 $22,570 - $26,080
82 Added 9.39%
955 $272,000
Q1 2023

Apr 20, 2023

SELL
$256.56 - $292.34 $13,084 - $14,909
-51 Reduced 5.52%
873 $242,000
Q4 2022

Feb 02, 2023

SELL
$252.44 - $306.72 $16,913 - $20,550
-67 Reduced 6.76%
924 $255,000
Q1 2022

Apr 29, 2022

BUY
$193.77 - $244.14 $3,875 - $4,882
20 Added 2.06%
991 $209,000
Q4 2021

Jan 21, 2022

SELL
$223.92 - $287.77 $13,211 - $16,978
-59 Reduced 5.73%
971 $233,000
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $11,319 - $14,762
-40 Reduced 3.74%
1,030 $291,000
Q2 2021

Jul 21, 2021

BUY
$259.0 - $414.71 $10,360 - $16,588
40 Added 3.88%
1,070 $370,000
Q1 2021

May 04, 2021

SELL
$242.95 - $284.63 $11,418 - $13,377
-47 Reduced 4.36%
1,030 $288,000
Q4 2020

Feb 01, 2021

SELL
$236.26 - $355.63 $110,097 - $165,723
-466 Reduced 30.2%
1,077 $264,000
Q3 2020

Nov 03, 2020

BUY
$264.77 - $305.71 $3,442 - $3,974
13 Added 0.85%
1,543 $438,000
Q2 2020

Jul 30, 2020

SELL
$258.66 - $342.55 $18,623 - $24,663
-72 Reduced 4.49%
1,530 $409,000
Q4 2019

Feb 27, 2020

BUY
$220.06 - $304.07 $248,007 - $342,686
1,127 Added 237.26%
1,602 $475,000
Q4 2019

Jan 27, 2020

SELL
$220.06 - $304.07 $266,712 - $368,532
-1,212 Reduced 71.84%
475 $475,000
Q3 2019

Oct 28, 2019

BUY
$217.44 - $243.88 $5,218 - $5,853
24 Added 1.44%
1,687 $393,000
Q2 2019

Aug 02, 2019

SELL
$219.29 - $241.72 $21,929 - $24,172
-100 Reduced 5.67%
1,663 $389,000
Q4 2018

Feb 08, 2019

BUY
$278.5 - $352.75 $490,995 - $621,898
1,763 New
1,763 $531,000
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $456,528 - $645,682
-1,755 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$307.64 - $344.58 $539,908 - $604,737
1,755 New
1,755 $559,000
Q3 2017

Nov 14, 2017

SELL
$281.15 - $329.69 $492,293 - $577,287
-1,751 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
1,751
1,751 $477,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Institute For Wealth Management, Llc. Portfolio

Follow Institute For Wealth Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institute For Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Institute For Wealth Management, Llc. with notifications on news.